sodium citrate in smell retraining for people with post-covid-19 olfactory dysfunction

Conditions: Long Haul COVID-19; Post-Acute COVID-19 Syndrome; Anosmia; Olfaction Disorders

Summary: the goal of this pilot study is to assess the feasibility and impact of using sodium citrate nasal spray as an adjunct to olfactory retraining in participants with long-term post-covid-19 olfactory dysfunction. the main questions it aims to answer are: * is sodium citrate nasal spray in addition to smell retraining feasible for participants to use in terms of participant need/desire, adherence, and adverse events? * does sodium citrate nasal spray in addition to smell retraining further improve smell as compared to normal saline spray and smell retraining? participants will: * provide consent for enrollment. * undergo smell testing via sniffin' sticks. * use a nasal spray (either sodium citrate or normal saline) followed by olfactory retraining twice a day for 12 weeks. * return for follow-up sniffin' sticks testing. researchers will compare the sodium citrate group and the normal saline group to determine differences in smell improvement.

background: loss of sense of smell is a hallmark of covid-19 infection. while about 80% of post-covid olfactory dysfunction (od) will experience some spontaneous recovery within 2 months of initial infection, about 20% will continue to suffer long-term.1 participants with persistent od suffer great disability including loss of pleasure with eating leading to weight loss and/or gain and other health risks, including possible dementia. further, loss of smell may lead to harm, with chief examples of inability to smell gas leaks or food that has gone bad. currently, use of "smell retraining" is recognized internationally as the most accepted method to treat patients with od, including post-viral or post-infectious od.2 some authors have extrapolated that smell retraining may be of benefit in post-covid od, however, data is sparse.3 increased extracellular calcium has been shown to inhibit the olfaction cascade occurring in the nose by either phosphorylating adenylate cyclase or by interacting and decreasing cyclic nucleotide-gated channels sensitivity to cyclin nucleotides. several studies have been performed to date using sodium citrate administered as a nasal spray to effectively reduce extracellular calcium resulting in temporary sense of smell benefit in those who have smell loss from a variety of causes, most significantly, post-viral or post-infectious loss (piod). several studies over the last two decades have examined the effect of sodium citrate on olfactory function in those with od (mainly post-infectious od) all of which have shown acute improvement in smell, peaking typically around 1 hour after application.4-7 most recently, in 2021 whitcroft et al conducted a controlled clinical trial on 60 piod participants. they applied sodium citrate intranasal spray to participants' right nostril for two weeks and olfaction was evaluated by sniffin' sticks composite tdi score both before the trial and after 2 weeks of sodium citrate use. they found a significant improvement in tdi score, though not reaching clinical significance. further, while the proportion of participants reporting parosmia did not change, there was a significant reduction in participants reporting phantosmia.8 the hypothesis is that the administration of sodium citrate to the nasal cavity, providing a temporary improvement in sense of smell, before the performance of smell retraining may augment its effects and yield better recovery in post-covid-19 od. purpose: the goal of this pilot study is to assess the feasibility and impact of using sodium citrate nasal spray as an adjunct to olfactory retraining in participants with long-term post-covid-19 olfactory dysfunction. participants: adults (\> 18 years) with \> 3 months of subjective olfactory loss. methods: all participants will undergo initial smell testing with the university of pennsylvania smell identification test (upsit) to confirm smell loss before enrollment. following screening and consent, enrollment will involve collecting participant data such as medication allergies, time between covid-19 infection and smell loss, previous smell loss therapies tried, presence of gustatory dysfunction, and use of paxlovid. participants; olfaction will then be objectively evaluated using "sniffin' sticks," a validated psychophysical tool that allows for more detailed assessment of odor threshold, discrimination, and identification. participants will be randomized into two groups and blinded. the sodium citrate arm will apply a nasal spray of sodium citrate (0.5 ml per nostril) and then perform olfactory training exercises, twice a day for 12 weeks the normal saline arm will apply a spray of normal saline (0.5 ml per nostril) and then perform olfactory training exercises, twice a day for 12 weeks. olfactory training will involve mindful inhalation of 4 primary odortants (lavender, clove, eucalyptus, and lemon), at least 20 seconds for each. all materials will be provided by advancedrx, who will also perform the randomization to ensure investigators are blind as well. nasal sprays will be shipped in 1-month quantities and adherence will be checked at the end of each month by assessing the amount of spray left in each bottle. during the 12 weeks, at days 7, 28, and 56, investigators will contact the participants to discuss if any adverse events have occurred. at the end of the 12 weeks, "sniffin' sticks" assessment will be repeated, and results compared within and between the groups. also, the number of eligible participants encountered, the number enrolled, the number who completed the study, the adherence rate, and the adverse event rates will be assessed within the overarching 1 year study period.

Eligibility criteria:
inclusion criteria: * provision of signed and dated informed consent form * stated willingness to comply with all study procedures and availability for the duration of the study * male and female, ages greater than or equal to 18 years. * patients with persistent olfactory dysfunction originating at the time of a confirmed covid-19 positive test occurring greater than 3 months ago. * ability to use nasal spray and be willing to adhere to the nasal spray and olfactory training regimen exclusion criteria: * treatment with another investigational drug or other intervention for olfactory dysfunction within the prior three months. * current smoker or inhaled tobacco use within the last three months. * history of chronic sinusitis or nasal polyps. * history of olfactory dysfunction following head trauma. * history of sinus or skull base surgery. * history of persistent olfactory dysfunction related to any other prior cause other than covid-19 infection. * congenital anosmia. * inability to return to unc health for follow-up.

Keywords: olfaction disorders sodium citrate covid-19 olfactory training